Why Aren’t More Doctors Prescribing Paxlovid to High-Risk Patients?
Recent evidence is piling up that many people at high risk for severe COVID-19 don’t receive nirmatrelvir/ritonavir (Paxlovid) — or any outpatient antiviral treatment — when diagnosed with a SARS-CoV-2 infection. MedPage Today looked at new studies and talked to experts to find out why. In a new observational study, people on Medicare who were […]